Luca Roncati

Prof. Dr. Luca Roncati

Department of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Polyclinic Hospital, I-41124 Modena (MO), Italy
+2
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Clinical Immunology
Verified
Journal Article
Closed access
Luca RoncatiLuca Roncati
Luca Roncati
GLGiulia Ligabue
Giulia Ligabue
LFLuca Fabbiani
Luca Fabbiani
CMClaudia Malagoli
Claudia Malagoli
GGGraziana Gallo
Graziana Gallo
AMAntonio Maiorana
Antonio Maiorana

8 May 2020 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
Luca RoncatiLuca Roncati
Luca Roncati
VNVincenzo Nasillo
Vincenzo Nasillo
BLBeatrice Lusenti
Beatrice Lusenti
GRGiovanni Riva
Giovanni Riva

28 August 2020 in Platelets
Verified
Journal Article
Closed access
Luca RoncatiLuca Roncati
Luca Roncati
GLGiulia Ligabue
Giulia Ligabue
VNVincenzo Nasillo
Vincenzo Nasillo
BLBeatrice Lusenti
Beatrice Lusenti
WGWilliam Gennari
William Gennari
AMAntonio Maiorana
Antonio Maiorana
Coronavirus disease 2019 (COVID-19) is a global public health emergency with many clinical facets, and new knowledge about its pathogenetic mechanisms is deemed necessary; among these, there are certainly coagulation disorders. In the history of medicine, autopsies and tissue sampling have played a fundamental role in order to understand the pathogenesis of emerging diseases, including infectious ones; compared to the past, histopathology can be now expanded by innovative techniques and modern technologies. For the first time in worldwide literature, we provide a detailed postmortem and biopsy report on the marked increase, up to 1 order of magnitude, of naked megakaryocyte nuclei in the bone marrow and lungs from serious COVID-19 patients. Most likely related to high interleukin-6 serum levels stimulating megakaryocytopoiesis, this phenomenon concurs to explain well the pulmonary abnormal immunothrombosis in these critically ill patients, all without molecular or electron microscopy signs of megakaryocyte infection.

Verified
Journal Article
Open access
PDF file
VNVincenzo Nasillo
Vincenzo Nasillo
GRGiovanni Riva
Giovanni Riva
APAmbra Paolini
Ambra Paolini
FFFabio Forghieri
Fabio Forghieri
Luca RoncatiLuca Roncati
Luca Roncati
TTTommaso Trenti
Tommaso Trenti
The Philadelphia-negative myeloproliferative neoplasms (MPNs) are malignancies of the hematopoietic stem cell (HSC) arising as a consequence of clonal proliferation driven by somatically acquired driver mutations in discrete genes (JAK2, CALR, MPL). In recent years, along with the advances in molecular characterization, the role of immune dysregulation has been achieving increasing relevance in the pathogenesis and evolution of MPNs. In particular, a growing number of studies have shown that MPNs are often associated with detrimental cytokine milieu, expansion of the monocyte/macrophage compartment and myeloid-derived suppressor cells, as well as altered functions of T cells, dendritic cells and NK cells. Moreover, akin to solid tumors and other hematological malignancies, MPNs are able to evade T cell immune surveillance by engaging the PD-1/PD-L1 axis, whose pharmacological blockade with checkpoint inhibitors can successfully restore effective antitumor responses. A further interesting cue is provided by the recent discovery of the high immunogenic potential of JAK2V617F and CALR exon 9 mutations, that could be harnessed as intriguing targets for innovative adoptive immunotherapies. This review focuses on the recent insights in the immunological dysfunctions contributing to the pathogenesis of MPNs and outlines the potential impact of related immunotherapeutic approaches.

1 September 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
Luca RoncatiLuca Roncati
Luca Roncati
BPBeniamino Palmieri
Beniamino Palmieri

1 July 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
Luca RoncatiLuca Roncati
Luca Roncati
GGGraziana Gallo
Graziana Gallo
AMAntonio Manenti
Antonio Manenti
BPBeniamino Palmieri
Beniamino Palmieri